Works matching IS 10538569 AND DT 2022 AND VI 31 AND IP 7
Results: 16
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 7, p. 1, doi. 10.1002/pds.5280
- Publication type:
- Article
Corrigendum.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 7, p. 815, doi. 10.1002/pds.5479
- Publication type:
- Article
A cross‐sectional survey to evaluate prescribers' knowledge and understanding of safety messages following Dengvaxia® product information update.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 7, p. 758, doi. 10.1002/pds.5447
- By:
- Publication type:
- Article
Applying mixture cure survival modeling to medication persistence analysis.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 7, p. 788, doi. 10.1002/pds.5441
- By:
- Publication type:
- Article
Trends in antipsychotic use for youth with attention‐deficit/hyperactivity disorder and disruptive behavior disorders.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 7, p. 810, doi. 10.1002/pds.5445
- By:
- Publication type:
- Article
Antibiotic use in children before, during and after hospitalisation.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 7, p. 749, doi. 10.1002/pds.5438
- By:
- Publication type:
- Article
International trends in prescription opioid sales among developed and developing economies, and the impact of the COVID‐19 pandemic: A cross‐sectional analysis of 66 countries.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 7, p. 779, doi. 10.1002/pds.5443
- By:
- Publication type:
- Article
Evaluating the population‐level effects of oxycodone restrictions on prescription opioid utilization in Ontario.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 7, p. 769, doi. 10.1002/pds.5442
- By:
- Publication type:
- Article
Alternative analytic and matching approaches for the prevalent new‐user design: A simulation study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 7, p. 796, doi. 10.1002/pds.5446
- By:
- Publication type:
- Article
COVID‐19 pharmacotherapy utilization patterns during pregnancy: International Registry of Coronavirus Exposure in Pregnancy.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 7, p. 804, doi. 10.1002/pds.5440
- By:
- Publication type:
- Article
Real‐world data: Assessing electronic health records and medical claims data to support regulatory decision‐making for drug and biological products.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 7, p. 717, doi. 10.1002/pds.5444
- By:
- Publication type:
- Article
How measurements affected by medication use are reported and handled in observational research: A literature review.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 7, p. 739, doi. 10.1002/pds.5437
- By:
- Publication type:
- Article
Categorization of COVID‐19 severity to determine mortality risk.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 7, p. 721, doi. 10.1002/pds.5436
- By:
- Publication type:
- Article
A risk classification model for prioritising the management of quality issues relating to substandard medicines in Singapore.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 7, p. 729, doi. 10.1002/pds.5434
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 7, p. 816, doi. 10.1002/pds.5280
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 7, p. 1, doi. 10.1002/pds.5280
- Publication type:
- Article